Roche gets boost on Avastin in lung cancer; Teva settles Medicare fraud probes for $169M;

 @FiercePharma: Decentralized NHS could be a sales-rep boon. Report | Follow @FiercePharma

> Some good Avastin news: the Roche drug won a renewed endorsement as a treatment for lung cancer from a clinical study looking at the drug's use in a broad, real-life setting. Story

> From a $169 million multistate settlement of Medicare fraud probes, Texas will receive $51.4 million from Teva Pharmaceutical, Attorney General Greg Abbott said. Report

> Abbott Laboratories (ABT.N) reported slightly higher-than-expected quarterly earnings, with strong sales growth from its array of prescription drugs, medical devices and nutritional products. News

> Anti-HIV drug maker Gilead Sciences said its second-quarter net income rose 25 percent, driven by sales of its antiviral drugs, but the results were short of expectations. Report

> Forest Laboratories' (FRX) fiscal first-quarter profit slumped 55 percent on litigation charges and product-licensing fees; sales improved and results beat analysts' expectations. Article

> Eli Lilly's price tag for Alnara Pharma could be as high as $380 million if the smaller company meets certain regulatory and commercial milestones. Report

> Reckitt Benckiser agreed to buy Durex condom maker SSL International for £2.54 billion ($3.9 billion), bolstering its health and personal-care business in the biggest acquisition since the company was formed in 1999. Story

> Mylan, the third-biggest generic drugmaker in the world, is spending €67 million on a packaging plant in the Hungarian city of Komarom, the company said Tuesday. Article

Biotech News

 @FierceBiotech: Study: Ecstacy may be useful in PTSD therapy. Report | Follow @FierceBiotech

> Merck buys vax unit from bankrupt Hawaii Biotech. Story

> Cara rounds up $15M for post-op pain drug. News

> Shionogi, GSK move HIV drug into PhIII. Article

Medical Device News

> J&J posts lower-than-expected earnings. Report

> Mass. students create portable ventilator. Story 

> Cardiac Science to replace faulty defibrillators. News

Drug Delivery News

> DOD taps Tekmira for Ebola treatment. Story

> Drug delivery expert helps Taris through bladder disease trials. Piece

> Access Pharma uses Trojan Horse to sneak into oral insulin. More

And Finally... Horses and polar bears and lizards, oh my! Check out the most interesting logos in biopharma. Slideshow

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.